CHMP recommends Minoryx’s ALD drug, rejects Zevra’s Meplyffanews2026-07-24T13:23:37+00:00July 24th, 2026|Endpoints News|
Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67news2026-07-24T11:00:10+00:00July 24th, 2026|Endpoints News|
Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitisnews2026-07-24T10:34:52+00:00July 24th, 2026|Endpoints News|
Gene editor Scribe starts second-half IPO spree with $129M listingnews2026-07-24T02:01:48+00:00July 24th, 2026|Endpoints News|
FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC-157news2026-07-23T18:34:12+00:00July 23rd, 2026|Endpoints News|
FDA to end pilot aimed at preventing production issuesnews2026-07-23T18:24:20+00:00July 23rd, 2026|Endpoints News|
Sartorius reduces revenue by €26M to refund Trump tariffs to customersnews2026-07-23T16:00:28+00:00July 23rd, 2026|Endpoints News|
Merck CEO cautions Congress on imposing limits on Chinese dealmakingnews2026-07-23T14:53:43+00:00July 23rd, 2026|Endpoints News|
Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugnews2026-07-23T14:47:25+00:00July 23rd, 2026|Endpoints News|
Biogen counts on drugs from Apellis deal to patch Leqembi’s slow salesnews2026-07-23T14:00:25+00:00July 23rd, 2026|Endpoints News|
